首页> 外国专利> WOUND TREATMENT GEL OBTAINABLE BY COMBINING PLATELET RICH PLASA WITH AUTOLOGOUSLY DERIVED THROMBIN

WOUND TREATMENT GEL OBTAINABLE BY COMBINING PLATELET RICH PLASA WITH AUTOLOGOUSLY DERIVED THROMBIN

机译:通过将富含血小板的PLASA与自体来源的凝血酶结合获得的伤口治疗凝胶

摘要

The present invention provides a method for preparing a wound treatment composition comprising the steps of; i) classifying the whole blood sample into a plurality of samples comprising a platelet rich plasma (PRP) sample, a platelet-poor plasma (PPP) sample and a red blood cell sample, wherein the PRP sample has a hematocrit level of 1-10%; ii) processing a portion of the PPP and/or PRP sample by promoting cleavage of the PPP and/or autologous prothrombin present in the PRP to produce autologous thrombin, and iii) treating the PRP sample to produce a wound treatment composition. combining a portion of the PPP sample and a portion of the thrombin produced in step (ii), wherein step ii) is performed at less than 15°C. In a preferred embodiment, the PRP has a hematocrit level of 2 or 8%. The wound treatment compositions produced by the methods are also provided as compositions for use in the treatment of chronic and acute wounds.
机译:本发明提供了一种制备伤口治疗组合物的方法,包括以下步骤:;i) 将全血样本分类为多个样本,包括富血小板血浆(PRP)样本、贫血小板血浆(PPP)样本和红细胞样本,其中PRP样本的红细胞压积水平为1-10%;ii)通过促进PRP中存在的PPP和/或自体凝血酶原的裂解来处理部分PPP和/或PRP样品,以产生自体凝血酶,以及iii)处理PRP样品以产生伤口治疗组合物。将一部分PPP样品和步骤(ii)中产生的一部分凝血酶结合起来,其中步骤(ii)在低于15°C的温度下进行。在优选实施例中,PRP的红细胞压积水平为2%或8%。通过所述方法制备的伤口治疗组合物也作为用于治疗慢性和急性伤口的组合物提供。

著录项

  • 公开/公告号KR20220035283A

    专利类型

  • 公开/公告日2022-03-21

    原文格式PDF

  • 申请/专利权人 바이오테라피 서비시스 리미티드;

    申请/专利号KR1020227007886

  • 发明设计人 해드필드 자넷;

    申请日2019-12-06

  • 分类号A61K35/16;A61K31/375;A61K35/19;A61K38/48;A61L26;A61P17/02;C08L89;

  • 国家 KR

  • 入库时间 2022-08-25 00:12:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号